ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04664	Fc epsilon RI signaling pathway	5/32	77/7206	1.96384997999e-05
ko04611	Platelet activation	6/32	163/7206	6.79821194849e-05
ko04640	Hematopoietic cell lineage	4/32	64/7206	0.000168855487325
ko04662	B cell receptor signaling pathway	4/32	88/7206	0.0005751334523
ko04650	Natural killer cell mediated cytotoxicity	4/32	97/7206	0.000830978835571
ko05152	Tuberculosis	5/32	187/7206	0.00127068143334
ko04666	Fc gamma R-mediated phagocytosis	4/32	122/7206	0.0019490581441
ko04514	Cell adhesion molecules (CAMs)	4/32	130/7206	0.00245869967652
ko04610	Complement and coagulation cascades	3/32	79/7206	0.00500423761433
ko04512	ECM-receptor interaction	3/32	79/7206	0.00500423761433
ko04151	PI3K-Akt signaling pathway	6/32	390/7206	0.00660187744691
ko00562	Inositol phosphate metabolism	3/32	89/7206	0.00697412320272
ko05340	Primary immunodeficiency	2/32	30/7206	0.00769093102971
ko04072	Phospholipase D signaling pathway	4/32	197/7206	0.0107016560244
ko05150	Staphylococcus aureus infection	2/32	36/7206	0.0109557229971
ko04659	Th17 cell differentiation	3/32	106/7206	0.0112593264667
ko04070	Phosphatidylinositol signaling system	3/32	112/7206	0.0130654101618
ko05144	Malaria	2/32	45/7206	0.0167947215407
ko04630	Jak-STAT signaling pathway	3/32	132/7206	0.0202318765274
ko04145	Phagosome	3/32	162/7206	0.0343491344989
ko05418	Fluid shear stress and atherosclerosis	3/32	173/7206	0.0405358395106
ko05140	Leishmaniasis	2/32	75/7206	0.0433619526423